Quantitative real-time assay for noroviruses and enteroviruses with built in quality control standard
Abstract
A method is provided for reverse transcription-polymerase chain reaction (RT-PCR) comprising a) amplifying a reverse transcribed cDNA in a mixture comprising Norovirus Genogroup I and Norovirus Genogroup II primers and probes, wherein said Norovirus primers and probes distinguish between Genogroup I and Genogroup II viruses; b) quantifying virus; and c) normalizing data based on a universal internal RNA control. Optionally, the method may also include primers and probes for Enteroviruses. A reaction mixture comprising Norovirus Genogroup I and Norovirus Genogroup II primers and probes, wherein said Norovirus primers and probes distinguish between Genogroup I and Genogroup II viruses and universal internal RNA control primers and probes are also included.
Claims
exact text as granted — not AI-modified1 . A method of reverse transcription-polymerase chain reaction (RT-PCR) comprising:
a) amplifying a reverse transcribed cDNA in a mixture comprising
i) an oligonucleotide probe and primers specific for Norovirus Genogroup I;
ii) an oligonucleotide probe and primers specific for Norovirus Genogroup I;
b) quantifying virus; and c) normalizing data to amplification of a universal internal RNA control in the same reaction mixture.
2 . The method of RT-PCR of claim 1 , wherein the primers specific for Norovirus Genogroup I comprise SEQ ID NO: 1 and SEQ ID NO:2.
3 . The method of RT-PCR of claim 1 , wherein the primers specific for Norovirus Genogroup II comprise SEQ ID NO: 5 and SEQ ID NO:6.
4 . The method of RT-PCR of claim 1 , wherein the oligonucleotide probe specific for Norovirus Genogroup I comprise SEQ ID NO: 3 and SEQ ID NO:4.
5 . The method of RT-PCR of claim 1 , wherein the oligonucleotide probe specific for Norovirus Genogroup II comprises SEQ ID NO:7.
6 . The method of RT-PCR of claim 1 , wherein the universal internal RNA control primers comprise SEQ ID NO:11 and SEQ ID NO:12.
7 . The method of RT-PCR of claim 1 , wherein the universal internal RNA control oligonucleotide probe comprises SEQ ID NO: 13.
8 . The method of RT-PCR of claim 1 , wherein the RT-PCR reaction mixture further comprises an oligonucleotide probe and primers specific for a RNA virus.
9 . The method of RT-PCR of claim 8 , wherein the RNA virus comprises rotavirus.
10 . The method of RT-PCR of claim 8 , wherein the RNA virus comprises a positive strand RNA virus.
11 . The method of RT-PCR of claim 10 , wherein the positive strand RNA virus comprises Hepatitcomprises A virus or an Enterovirus group virus.
12 . The method of RT-PCR of claim 11 , wherein the Enterovirus group virus comprises poliovirus, coxsackievirus, echovirus, or enterovirus.
13 . The method of RT-PCR of claim 9 , wherein the coxsackievirus comprises coxsackievirus Group A or coxsackievirus Group B.
14 . The method of RT-PCR of claim 1 , wherein said cDNA comprises reverse transcribed from RNA in a biological sample.
15 . The method of RT-PCR of claim 11 , wherein said biological sample comprises blood, urine, or a stool sample.
16 . The method of RT-PCR of claim 1 , wherein said cDNA comprises reverse transcribed from RNA in a food sample.
17 . The method of RT-PCR of claim 13 , wherein said food sample comprises shellfish.
18 . The method of RT-PCR of claim 1 , wherein said cDNA comprises reverse transcribed from RNA in a water sample.
19 . The method of RT-PCR of claim 15 , wherein said water sample comprises wastewater, ocean water, lake water, river water, groundwater, or recreational water.
20 . A reverse transcription polymerase chain reaction (RT-PCR) mixture comprising:
a) an oligonucleotide probe and primers specific for Norovirus Genogroup I; b) an oligonucleotide probe and primers specific for Norovirus Genogroup I; c) a universal internal nucleic acid molecule, wherein said molecule contains at least one forward primer annealing site, at least one reverse primer annealing site, and at least on amplifiable region; d) a universal internal control oligonucleotide probe; and e) a universal internal control primers.
21 . The RT-PCR mixture of claim 17 , wherein said oligonucleotide probe includes a detectable label.
22 . The RT-PCR mixture of claim 17 , wherein the primers specific for Norovirus Genogroup I comprise SEQ ID NO: 1 and SEQ ID NO:2.
23 . The RT-PCR mixture of claim 17 , wherein the primers specific for Norovirus Genogroup II comprise SEQ ID NO: 5 and SEQ ID NO:6.
24 . The RT-PCR mixture of claim 17 , wherein the oligonucleotide probe specific for Norovirus Genogroup I comprise SEQ ID NO: 3 and SEQ ID NO:4.
25 . The RT-PCR mixture of claim 17 , wherein the oligonucleotide probe specific for Norovirus Genogroup II comprises SEQ ID NO:7.
26 . The RT-PCR mixture of claim 17 , wherein the universal internal RNA control primers comprise SEQ ID NO:11 and SEQ ID NO:12.
27 . The RT-PCR mixture of claim 17 , wherein the universal internal RNA control oligonucleotide probe comprises SEQ ID NO: 13.
28 . The RT-PCR mixture of claim 17 , wherein the RT-PCR mixture further comprises primers and oligonucleotide probes specific for detection of a RNA virus.
29 . The RT-PCR mixture of claim 28 , wherein the RNA virus comprises rotavirus.
30 . The RT-PCR mixture of claim 28 , wherein the RNA virus comprises a positive strand RNA virus.
31 . The RT-PCR mixture of claim 30 , wherein the positive strand RNA virus comprises Hepatitis A virus or an Enterovirus group virus.
32 . The RT-PCR mixture of claim 31 , wherein the Enterovirus group comprises poliovirus, coxsackievirus, echovirus, or enterovirus.
33 . The RT-PCR mixture of claim 32 , wherein the coxsackievirus comprises coxsackievirus Group A or coxsackievirus Group B.
34 . A RT-PCR kit comprising:
a) an oligonucleotide probe and primers specific for Norovirus Genogroup I; b) an oligonucleotide probe and primers specific for Norovirus Genogroup I; c) a universal internal nucleic acid molecule, wherein said molecule contains at least one forward primer annealing site, at least one reverse primer annealing site, and at least on amplifiable region; d) a universal internal RNA control probe; and e) a universal internal RNA control primers in a package.
35 . The kit of claim 28 wherein the kit further comprises instructions for use.Join the waitlist — get patent alerts
Track US2006110724A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.